skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 9
Patent #:
6599891
Issue Dt:
07/29/2003
Application #:
10199662
Filing Dt:
07/19/2002
Publication #:
20030099596
Pub Dt:
05/29/2003
Inventors:
Janice North, Peter Hnik, H. Andrew Strong
Title:
TREATMENT OF MACULAR EDEMA
Assignment: 1
Reel/Frame:
013440/0646Recorded: 10/28/2002Pages: 2
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
NORTH, JANICE
Exec Dt:
09/23/2002
HNIK, PETER
Exec Dt:
09/26/2002
STRONG, H. ANDREW
Exec Dt:
09/28/2002
Assignee:
QLT INC.
887 GREAT NORTHERN WAY
VANCOUVER BC V5T 4T5, CANADA
Correspondent:
MORRISON & FOERSTER LLP
KAWAI LAU
3811 VALLEY CENTRE DRIVE
SUITE 500
SAN DIEGO, CA 92130-2332
Assignment: 2
Reel/Frame:
031784/0833Recorded: 12/09/2013Pages: 58
Conveyance:
PATENT ASSIGNMENT AGREEMENT
Assignors:
QLT INC.
Exec Dt:
09/24/2012
QLT OPHTHALMICS, INC.
Exec Dt:
09/24/2012
Assignee:
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
4787 LEVY STREET
MONTREAL, QUEBEC, CANADA H4R 2P9
Correspondent:
SKADDEN ARPS SLATE MEAGHER & FLOM LLP
FOUR TIMES SQUARE
ATTN: REBECCA RODAL, ESQ.
NEW YORK, NY 10036
Assignment: 3
Reel/Frame:
032897/0450Recorded: 05/15/2014Pages: 3
Conveyance:
ADDRESS CHANGE
Assignor:
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Exec Dt:
09/24/2012
Assignee:
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
2150 ST. ELZEAR BLVD. WEST
LAVAL, QUEBEC, CANADA H7L 4A8
Correspondent:
STERNE, KESSLER, GOLDSTEIN & FOX PLLC
1100 NEW YORK AVENUE
WASHINGTON, DC 20005
Assignment: 4
Reel/Frame:
039380/0385Recorded: 07/18/2016Pages: 21
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
ATON PHARMA, INC.
Exec Dt:
07/18/2016
BAUSCH & LOMB INCORPORATED
Exec Dt:
07/18/2016
BAUSH & LOMB PHARMA HOLDINGS CORP.
Exec Dt:
07/18/2016
DENDREON PHARMACEUTICALS, INC.
Exec Dt:
07/18/2016
DOW PHARMACEUTICAL SCIENCES, INC.
Exec Dt:
07/18/2016
MEDICIS PHARMACEUTICAL CORPORATION
Exec Dt:
07/18/2016
OBAGI MEDICAL PRODUCTS, INC.
Exec Dt:
07/18/2016
OMP, INC.
Exec Dt:
07/18/2016
ORAPHARMA, INC.
Exec Dt:
07/18/2016
PRECISION DERMATOLOGY, INC.
Exec Dt:
07/18/2016
SALIX PHARMACEUTICALS, INC.
Exec Dt:
07/18/2016
SALIX PHARMACEUTICALS, LTD
Exec Dt:
07/18/2016
SANTARUS, INC.
Exec Dt:
07/18/2016
SOLTA MEDICAL, INC.
Exec Dt:
07/18/2016
VALEANT CANADA LP, BY ITS GENERAL PARTNER VALEANT CANADA GP LIMITED
Exec Dt:
07/18/2016
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Exec Dt:
07/18/2016
VALEANT HOLDINGS IRELAND (AS SUCCESSOR TO VALEANT INTERNATIONAL BERMUDA)
Exec Dt:
07/18/2016
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Exec Dt:
07/18/2016
VALEANT PHARMACEUTICALS IRELAND
Exec Dt:
07/18/2016
Assignee:
BARCLAYS BANK PLC
745 SEVENTH AVENUE
27TH FLOOR
NEW YORK, NEW YORK 10019
Correspondent:
SKADDEN, ARPS, SLATE, MEAGHER & FLOM
FOUR TIMES SQUARE
MONIQUE L. RIBANDO
NEW YORK, NY 10036
Assignment: 5
Reel/Frame:
043045/0959Recorded: 07/19/2017Pages: 9
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Exec Dt:
07/17/2017
Assignee:
THE BANK OF NEW YORK MELLON
101 BARCLAY STREET
FLOOR 7E
NEW YORK, NEW YORK 10286
Correspondent:
STEWART WALSH
1025 VERMONT AVE NW, SUITE 1130
COGENCY GLOBAL INC.
WASHINGTON, DC 20005
Assignment: 6
Reel/Frame:
045444/0299Recorded: 02/26/2018Pages: 69
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
ATON PHARMA, INC.
Exec Dt:
02/13/2018
BAUSCH & LOMB INCORPORATED
Exec Dt:
02/13/2018
BAUSCH & LOMB PHARMA HOLDINGS CORP.
Exec Dt:
02/13/2018
COMMONWEALTH LABORATORIES, LLC
Exec Dt:
02/13/2018
DOW PHARMACEUTICAL SCIENCES, INC.
Exec Dt:
02/13/2018
ECR PHARMACEUTICALS CO., INC.
Exec Dt:
02/13/2018
LABORATOIRE CHAUVIN S.A.S.
Exec Dt:
02/13/2018
MEDICIS PHARMACEUTICAL CORPORATION
Exec Dt:
02/13/2018
ONPHARMA INC.
Exec Dt:
02/13/2018
ORAPHARMA, INC.
Exec Dt:
02/13/2018
PRECISION DERMATOLOGY, INC.
Exec Dt:
02/13/2018
SALIX PHARMACEUTICALS, LTD.
Exec Dt:
02/13/2018
SALIX PHARMACEUTICALS, INC.
Exec Dt:
02/13/2018
SANTARUS, INC.
Exec Dt:
02/13/2018
SOLTA MEDICAL, INC.
Exec Dt:
02/13/2018
SYNERGETICS USA, INC.
Exec Dt:
02/13/2018
TECHNOLAS PERFECT VISION GMBH
Exec Dt:
02/13/2018
VALEANT CANADA LP
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS INTERNATIONAL
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Exec Dt:
02/13/2018
WIRRA IP PTY LIMITED
Exec Dt:
02/13/2018
VALEANT PHARMA POLAND SP. Z O.O.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS IRELAND LIMITED
Exec Dt:
02/13/2018
Assignee:
BARCLAYS BANK PLC, AS COLLATERAL AGENT
745 SEVENTH AVENUE
NEW YORK, NEW YORK 10019
Correspondent:
MELONY SOT
1025 VERMONT AVE NW, SUITE 1130
COGENCY GLOBAL INC.
WASHINGTON, DC 20005
Assignment: 7
Reel/Frame:
045444/0634Recorded: 02/26/2018Pages: 69
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
ATON PHARMA, INC.
Exec Dt:
02/13/2018
BAUSCH & LOMB INCORPORATED
Exec Dt:
02/13/2018
BAUSCH & LOMB PHARMA HOLDINGS CORP.
Exec Dt:
02/13/2018
COMMONWEALTH LABORATORIES, LLC
Exec Dt:
02/13/2018
DOW PHARMACEUTICAL SCIENCES, INC.
Exec Dt:
02/13/2018
ECR PHARMACEUTICALS CO., INC.
Exec Dt:
02/13/2018
LABORATOIRE CHAUVIN S.A.S.
Exec Dt:
02/13/2018
MEDICIS PHARMACEUTICAL CORPORATION
Exec Dt:
02/13/2018
ONPHARMA INC.
Exec Dt:
02/13/2018
ORAPHARMA, INC.
Exec Dt:
02/13/2018
PRECISION DERMATOLOGY, INC.
Exec Dt:
02/13/2018
SALIX PHARMACEUTICALS, LTD.
Exec Dt:
02/13/2018
SALIX PHARMACEUTICALS, INC.
Exec Dt:
02/13/2018
SANTARUS, INC.
Exec Dt:
02/13/2018
SOLTA MEDICAL, INC.
Exec Dt:
02/13/2018
SYNERGETICS USA, INC.
Exec Dt:
02/13/2018
TECHNOLAS PERFECT VISION GMBH
Exec Dt:
02/13/2018
VALEANT CANADA LP
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS INTERNATIONAL
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Exec Dt:
02/13/2018
WIRRA IP PTY LIMITED
Exec Dt:
02/13/2018
VALEANT PHARMA POLAND SP. Z O.O.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS IRELAND LIMITED
Exec Dt:
02/13/2018
Assignee:
THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
101 BARCLAY STREET
FLOOR 7E
NEW YORK, NEW YORK 10286
Correspondent:
MELONY SOT
1025 VERMONT AVE NW, SUITE 1130
COGENCY GLOBAL INC.
WASHINGTON, DC 20005
Assignment: 8
Reel/Frame:
049672/0652Recorded: 07/03/2019Pages: 27
Conveyance:
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Assignors:
BAUSCH HEALTH IRELAND LIMITED
Exec Dt:
07/01/2019
BAUSCH HEALTH COMPANIES INC.
Exec Dt:
07/01/2019
BAUSCH HEALTH, CANADA INC.
Exec Dt:
07/01/2019
TECHNOLAS PERFECT VISION GMBH
Exec Dt:
07/01/2019
VALEANT PHARMACEUTICALS LUXEMBOURG S.À R.L.
Exec Dt:
07/01/2019
VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA
Exec Dt:
07/01/2019
VALEANT SP. Z O. O.
Exec Dt:
07/01/2019
Assignee:
THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
240 GREENWICH STREET
ATTN: CORPORATE TRUST ADMINISTRATION
NEW YORK, NEW YORK 10286
Correspondent:
JAY DASILVA
1025 VERMONT AVE NW, SUITE 1130
COGENCY GLOBAL INC.
WASHINGTON, DC 20005
Assignment: 9
Reel/Frame:
057821/0800Recorded: 10/05/2021Pages: 18
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
BAUSCH & LOMB IRELAND LIMITED
Exec Dt:
10/04/2021
BAUSCH HEALTH COMPANIES INC.
Exec Dt:
10/04/2021
DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH
Exec Dt:
10/04/2021
TECHNOLAS PERFECT VISION GMBH
Exec Dt:
10/04/2021
Assignee:
THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
240 GREENWICH STREET
CORPORATE TRUST ADMINISTRATION
NEW YORK, NEW YORK 10286
Correspondent:
JENNIFER TINDIE
1025 CONNECTICUT AVE., NW, SUITE 712
COGENY GLOBAL INC.
WASHINGTON, DC 20036

Search Results as of: 05/04/2024 01:59 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT